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Abstract 
A variant of lactate dehydrogenase (LDHB * GUAI) was previously identified among the Guaymi Indians of Panama nd Costa Rica. 
Tb~ LDHB ~ GUAI variant is enzymatically inactive; however, the variant subunits alter the electrophoretic mobility of the tetramers that 
include active LDHA and LDHB subunits. The kinetic properties of the tetrameric enzyme, comprised of inactive B plus active A 
subunits, are similar to properties of the heterotetramers with active B subunits, except for the reduced specific activity. We have 
determined that a single C. G to T. A transition changes an Arg to a Trp at amino acid residue 106. This substitution explains the 
increase in net negative charge observed by protein electrophoresis. This Arg 106 residue is absolutely conserved throughout evolution. 
Published high-resolution crystal structures of LDH reveal that this residue is within the hinge of a loop that closes over the active site of 
the subunit upon binding of substrate and cofactor and also has a direct role in catalysis. Computer modeling of the variant enzyme 
suggests that replacement of this Arg residue with a Trp does not induce significant change in the structure of the active site. However, 
this substitution would result in disruption of enzyme activity through the inability of the uncharged tryptophan side-chain to polarize the 
substrate carbonyl bond. This would explain the loss of catalytic function with maintenance of normal kinetic properties in the 
heterotetramers containing the variant subunits. The ability to maintain ormal, tissue-specific kinetic properties could explain the absence 
of clinical manifestations in the homozygous LDHB* GUA1 individuals. 
Kewcords: Lactate dehydrogenase B variant; Lactate dehydrogenase B catalysis; Subunit structure; Enzyme activity variant 
1. Introduction 
Lactate dehydrogenase (LDH; E.C.1.l.1.27) is the en- 
zyme in the glycolytic pathway that converts pyruvate to 
lactate. It has been extremely well characterized; the genet- 
ics, sequence, and crystal structure of this enzyme have 
been determined, and its catalytic mechanism has been 
extensively studied [1]. In mammals, the enzyme is en- 
coded by three genes: LDHA (M or muscle form), LDHB 
(H or heart form), and LDHC (X or testis specific form) 
[1]. The human LDHB gene is approx. 25 kb in length and 
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is comprised of eight exons encoding for a protein of 333 
amino acids [2]. Both LDHA and LDHB are present in all 
tissues but the ratio of LDHA to LDHB subunits and the 
isozyme profile is tissue-specific. Approx. 80% of the 
activity in both human heart and erythrocytes i  associated 
with the LDHB isozyme, while liver expresses primarily 
the LDHA protein. The functional enzyme is a tetramer 
with five isozymic forms, resulting from all possible com- 
binations of the A and B subunits [3]. The kinetic and 
stability properties of the heterotetramers are intermediate 
to those of the A 4 and B 4 homotetramers [4]. 
LDH is only active as a tetramer, but each subunit is 
capable of forming a ternary complex composed of sub- 
strate (pyruvate/lactate) and coenzyme (NADH/NAD +) 
[1]. A surface loop of 24 residues moves approx. 10 A to 
close over the active site when substrate/cofactor a e 
bound [5]. This loop closure is the rate-limiting step in 
catalysis [6,7]. The closure of the loop is accomplished via 
a 'cog-hopping-between-grooves' mechanism involving 
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loop residue Arg-109 (residue 109 in X-ray numbering or 
Arg 106 in GenBank) in the hinge [5]. X-ray crystallogra- 
phy studies indicate that loop closure brings the positive 
charge of this Arg-109 residue into the active site, where it 
polarizes the substrate carbonyl bond. This aids proton 
(H +) transfer from the active site His-195 to the carbonyl 
oxygen and hydride ion (H-) transfer from NADH to the 
carbonyl carbon of pyruvate during substrate reduction 
(Fig. 1A) [8,9]. Thus, Arg 109 would appear to be a key 
residue in this enzyme. 
A variant of human LDHB, LDHB * GUAI ,  was identi- 
fied as an electromorph with increased net negative charge 
among the Guaymi Indians of Panama and Costa Rica 
[I0-12]. Biochemical characterization confirmed that the 
LDHB*GUAI  subunits were catalytically inactive but 
formed tetramers with normal A and/or  B subunits. The 
specific activity of the heterotetramers was reduced in 
proportion to the number of variant subunits, but the 
kinetic properties and stability of the heterotetramers of A 
plus B * GUA1 subunits was similar to the properties of 
heterotetramers of A plus normal B subunits [ 13]. 
Here we report the identification of an Arg 109 (X-ray 
numbering) to Trp substitution i the LDHB * GUAI  vari- 
ant. Computer modeling of the Arg to Trp substitution 
suggests that this amino acid substitution has minimal 
impact on the conformation of the active site and that the 
loss of function is the result of a direct effect on catalysis. 
2. Material  and methods 
2.1. Source of materials 
Blood samples were collected from Guaymi Indians in 
eastern Costa Rica [12]. Polyacrylamide gel electrophoretic 
analysis identified individuals that were heterozygous and 
homozygous for the LDHB* GUA1 variant. Subsequent 
quantitation of erythrocyte LDH activity confirmed the 
electrophoretic analysis [ 13]. Leucocytes were isolated from 
whole blood and stored at -20°C until genomic DNA was 
isolated [14]. DNA from a lymphoblastoid cell line (TK-6) 
served as a control [14]. 
2.2. Oligonucleotide primers 
Oligonucleotide primers, homologous either to pub- 
l ished human LDHB genomic DNA sequence 
Table 1 
PCR and sequencing primers for human LDHB 
Exon a Type b Id c Sequence ~ Mg e °C f Size g 
1 FP 1 TGGCCTCCGCATTGAAGAGCCTG Ix 58 ° 604 
RP 2 TCTCCGCTGAGCCGCAGCTGCTA 
1 F S 22 CTAAGAGGCTGCGGTGGTTGTGG 
R S 23 ACTACCCCGCACGTCCCATCAG 
2 FPS 29 TTTTAAGGATGATTTCTATTTGGATTTC 2x 58 ° 510 
RP 19 ATAAACGGCATGATTTTGAC 
R S 24 ATTCCAAGGTGCCCAAAGAAACTG 
FPS 30 GATTGTGAGCTGAGGCATCCTAGAGTGG 1 x 58 ° 208 
RPS 6 GATCACTTTGGGCATTAAGTGAAA 
FPS 31 GAGTTGCATTTAAAGTACCTG'ITTTTGC I x 58 ° 268 
RPS 13 CCAAACAATAACAACAAAAACACC 
FP 31 GAGTTGCATTTAAAGTACCTGTI'TTI'GC 1 x 58 ° < 2500 
RPS 32 TTCAAAATGGCAAAACCAACATCACAAG 
FPS 38 AAGTTGGTTTTGGTTTACTTAC 2x 50 ° 275 
RPS 32 TI'CAAAATGGCAAAACCAACATCACAAG 
FPS 25 TTTTTTTTI'TrTAAACAGTGGCTG 2x 52 ° < 1500 
RPS 26 AAATGAATCTTTTTGTAGAATACAATGCT 
FPS 25 TTTI'TTTTTTTTAAACAGTGGCTG 2x 58 ° 188 
RPS 36 ATTTAAGTAGAGTTGAAATTAATCATCTAAAATC 
FPS 37 TTCAATAATGATTGAGTCTTATTTCAGTG 2x 58 ° 242 
RPS 26 AAATGAATCTTTI'TGTAGAATACAATGCT 
FP 11 CACTGAAGCTTCAAACTCCTGGGCTCA lx 58 ° 753 
RP 12 AATGTCATATACATTGACATCCG 
FS 27 CCTCCCACCTCAGCCTCCTGTCTTTG 
RS 28 ATGACGTGTGGTAAGAATGACTTGGCAG 
3 
4 
4+5 
5 
6+7 
6 
7 
8 
8 
Exon, exon number according toEMBL/GenBank numbering. 
b Type, F, forward primer; R, reverse primer; P, primer used for PCR amplification f sequencing template; S, primer end-labeled with v33p and used in 
sequencing reaction. 
c Id, primer identification number. 
d Sequence, primer sequence in 5' to 3' direction. 
Mg, concentration of Mg in PCR reaction, 1× = 1.5 mM MgC12. 
f °C, annealing temperature sed in PCR reaction. 
g Size, length in base pairs of PCR product. 
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(EMBL/GenBank Data Library Accession Numbers 
X13794 to X13800) or sequence determined in these stud- 
ies, were designed using PRIMER: A Computer Program 
for Automatically Selecting PCR Primers [15]. Primers 
were synthesized on a Model 394 DNA Synthesizer (Ap- 
plied Biosystems, Foster City, CA). Table 1 contains the 
primer sequences for amplifying and sequencing the eight 
LDHB exons. All sequencing primers were purified using 
Nensorb Prep Nucleic Acid Purification Columns (Du 
Pont, NEN Research Products, Boston, MA). 
2.3. PCR amplification 
All eight LDHB exons (numbered here as 1-8 in accord 
with the GenBank Data Base, alternatively numbered as 
0-7 [2]) were individually amplified [16] from genomic 
DNA. PCR primers, homologous only to intronic se- 
quences, were used for those exons for which sufficient 
flanking intronic sequence was available in the 
EMBL/GenBank Data Library. For exons 5 (5' end), 6 (5' 
and 3' ends), and 7 (5' end), the first set of PCR primers 
overlapped with several bases of each exon. Published 
PCR conditions [17] were used with Hot Start PCR (Perkin 
Elmer Cetus, Norwalk, CT). Cycle parameters were: denat- 
uration 95°C, 30 s; annealing 50-58°C (depending on 
primers, see Table 1), 30 s; extension 72°C, 1 min; 35 
cycles; followed by 72°C, 5 rain to ensure full-length 
products. 
2.4. DNA sequencing 
Freshly amplified PCR template was purified using 
Wizard PCR Preps DNA Purification System (Promega, 
Madison, WI) and cycle sequenced using the fmol DNA 
Sequencing System (Promega) with y33p end-labeled 
primers and 400 fmol of template DNA per reaction. 
Depending on the exon, sequencing primers were either 
identical to PCR primers, or were internal to them (Table 
1). DNA sequences masked by PCR primers that over- 
lapped with regions of exons 5, 6, and 7 were obtained as 
described for the 5' end of exon 5 below. Primers 31 and 
32 were used to amplify a DNA segment containing exon 
4, intron 4, and exon 5. This DNA segment served as 
template and was sequenced in a 3' to 5' direction using 
primer 32, sequencing through exon 5 into the 3' end of 
intron 4. Sufficient intron 4 sequence was thus obtained to 
design primer 38, homologous to only intronic DNA, 
permitting complete sequencing of the 5' end of exon 5 on 
both strands. Despite repeated attempts, we were unable to 
amplify across intron 5, Therefore, the first 6 bases of 
exon 6 were masked by primer 25 and could not be 
sequenced. 
2.5. Computer modeling 
X-ray structures utilized in modeling the LDHB * GUAl 
variant subunit were the two highest resolution LDHA and 
the sole LDHB abortive ternary complexes (Brookhaven 
Protein Data Bank, PDB) [18]. These are: Dogfish muscle 
LDH-NAD-oxamate solved to 2.1 ~, with an R factor of 
0.17 (unpublished refinement by J.P. Griffith and M.G. 
Rossmann, PDB file 1LDM); pig muscle LDH-NAD- 
oxamate solved to 2.2 A with an R factor of 0.22 [19] 
(PDB file 9LDB); pig heart LDH-S-lac-NAD solved to 2.7 
o 
A with an R factor of 0.20 [20] (PDB file 5LDH). 
Models of LDHB* GUA1 were generated from each of 
these three closed-loop LDH structures by replacing Arg- 
109 with a Trp residue. The small molecules NAD and 
oxamate were retained in the mutant proteins generated 
from the 1LDM and 9LDB coordinate files so that the 
potential interference of Trp-109 with substrate and co-fac- 
tor binding could be investigated. Likewise, S-Iac-NAD 
was retained in the mutant generated from the 5LDH 
coordinate file. Possible conformations of the Trp side- 
chain were evaluated by calculating the energies of the 
LDHB* GUA1 model structures with the Trp side-chain 
rotated about the torsional angles X ~ =(N-C%C~-CV) 
and &,2 = (C,_C ,_Cv_CS~) in 10 ° intervals; all other atoms 
were held fixed to their original coordinates. Contour plots 
of torsional angles vs. energy for each LDHB*GUAI 
model were analyzed, and representative structures were 
selected from each local energy minimum. The selected 
structures were then further optimized by holding each 
model fixed and allowing the conformations of the entire 
Trp-109 residue to be energy minimized to convergence by 
successive use of Steepest Descents and Adopted Basis 
Newton-Raphson algorithms. The computer modeling pro- 
grams CHARMm [21] and QUANTA (Molecular Simula- 
tions, Waltham, MA) were used for this study. 
3. Results and discussion 
3.1. Analys& of  ~,ariant allele 
PCR amplification of each of the 8 exons resulted in a 
single product for each exon, as determined by elec- 
trophoresis on agarose gels. Both strands of all 8 exons 
were sequenced in the DNA from a homozygous 
LDHB * GUA1 individual. With the exception of a C - G to 
T. A transition in the codon for Arg-106 (CGG) in exon 4, 
the coding sequence was identical to the published se- 
quence (EMBL/GenBank Data Library Accession Num- 
bers X13794 to X13800. This resulted in a change to a 
codon for Trp (TGG). This substitution was confirmed by 
PCR amplification and sequencing of both strands of exon 
4 from a second homozygous LDHB* GUAI variant indi- 
vidual. The sequence of a control individual matched the 
published LDHB sequence (Accession Number X13796). 
The substitution of an uncharged Trp residue for the 
positively charged Arg-106 residue (GenBank sequence 
numbering) is consistent with the increase in net negative 
charge of the variant LDHB* GUA1 subunit observed by 
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polyacrylamide gel electrophoresis [13]. It is unlikely that 
a second mutation with biochemical relevance xists in 
one of the bases masked by primer 25, as the mutation 
described in this paper accounts for all observed character- 
istics of the inactive subunit. The three amino acids en- 
coded by these unsequenced bases are located in a noncon- 
served region that is not part of the active site [22]. The 
Arg to Trp substitution in the LDHB * GUA1 variant re- 
ported here differs from previously described sequence 
variants associated with LDHB deficiency in humans [23- 
25]. 
3.2. Importance of Arg-109 
A S 
H i ~  '~ oxamate 
NADH 
The Arg-106 residue is numbered Arg-109 in X-ray 
crystallographic papers published prior to the availability 
of sequence data [22]; for consistency with these refer- 
ences, all amino acid residues will be referred to by their 
original X-ray numbering for the remainder of this paper. 
Arg-109 is located in one hinge of a loop that moves 
roughly 10 A to close over the active site of the subunit 
following substrate and coenzyme binding. This loop of 24 
residues is highly conserved and the Arg-109 residue is 
absolutely conserved among 17 LDH sequences from 10 
eukaryotic and 7 prokaryotic organisms [5]. 
The absolute conservation suggests that Arg-109 has a 
critical function in loop closure and/or catalysis. In the 
closed-loop conformation, the positive charge of Arg-109 
is in close proximity to both His-195 and the carbonyl 
oxygen of the substrate [20]. His-195 is the proton donor to 
the carbonyl oxygen of pyruvate, while the dihydronicoti- 
namide ring of NADH is the hydride ion donor to the 
carbonyl carbon during reduction of pyruvate to lactate 
(Fig. 1A). A site-directed mutagenesis experiment [26], 
which replaced the positively charged Arg-109 with a 
neutral Gln, resulted in a 420-fold reduction in the cat- 
alytic rate (k~.~t) of LDH. This study of the Gln-109 variant 
[26], and subsequent investigations by Deng et al. [9], 
demonstrated that the positive charge of Arg-109 is critical 
for polarizing the carbonyl bond; hydride ion transfer from 
NADH to the substrate requires a strongly polarized sub- 
strate carbonyl group to draw electrons from the dihydroni- 
cotinamide ring of NADH [7,8]. 
The interaction of Arg-109 with the substrate, and its 
presence in the loop, suggests that the Arg to Trp mutation 
could disrupt enzyme activity for several reasons. Steric 
hindrance between the less flexible Trp side-chain and 
elements of the active site may interfere with loop closure 
or disrupt he structure of the active site. Additionally, the 
neutral Trp side-chain may not be able to contribute to the 
catalytic mechanism even if a normal closed-loop confor- 
mation of the active site is achieved. Thus the C. G to 
T • A transition in exon 4 of the variant allele appears to be 
sufficient o account for the characteristics of the variant 
enzyme. The Trp for Arg substitution would result in an 
enzyme with increased net negative charge and the loss of 
' oxamate 
NADH 
Fig. 1. (A) Active site of an LDH-oxamate-NAD complex showing only 
Arg-109, His-195, the dihydronicotinamide ring of NADH, and oxamate 
(an isosteric and isoelectronic unreactive analog of pyruvate). Hatched 
line indicates the electrostatic nteraction between the positively charged 
Arg-109 guanidinium group and the substrate carbonyl oxygen. This 
interaction results in the polarization of the carbonyl bond necessary for 
full enzymatic activity. Coordinates are from the PDB file ILDM. C, O, 
and N atoms are represented by black, gray, and white spheres, respec- 
tively. (B) Active site of an energy-minimized LDHB ~ GUA1 model. The 
hydrogen bond between the Trp side-chain polar amide hydrogen and the 
carbonyl oxygen of the substrate (dashed line) is similar to, but weaker 
than, the Arg-109-substrate interaction observed in wild-type LDH. No 
unfavorable contacts are apparent for Trp-109 in this conformation. The 
LDHB* GUA1 model depicted is the result of energy minimization of 
Trp-109 introduced into coordinate file ILDM with initial side-chain 
torsional angles X ~= -47  ° and X 2= 86 °. Similar structures resulted 
using coordinate files 9LDB and 5LDH (PDB). 
the Arg residue, which has a direct role in catalysis, would 
explain the loss of enzymatic activity. 
3.3. Interference of Trp-109 with catalytic actit, it3, 
Possible steric interference of Trp-109 with loop closure 
and active site conformation was addressed with computer 
modeling. We examined the potential for the Trp side-chain 
to be accommodated in the active site of crystal structures 
of abortive (closed-loop conformation) LDH complexes. 
While the structure of human LDHB has not been solved, 
high resolution X-ray crystallographic structures of dogfish 
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LDHA (ILDM), pig LDHA (9LDB), and pig LDHB 
(5LDH) are available (PDB). The three structures are very 
similar at the available resolution. Human LDHB and the 
most unrelated of these three structures (dogfish LDHA) 
have an amino acid identity of 73% and a similarity of 
87%. With such high sequence identity, the root mean 
square deviation of the backbone atoms for each of these 
structures is expected to differ from the actual human 
LDHB structure by less than 1 ,~ [27]. Therefore, these 
three published structures are appropriate for use as mod- 
els of the human LDHB*GUA1 variant by replacing 
Arg-109 with a Trp residue. 
Given previous data that the enzymatically inactive 
LDHB* GUAI variant subunits affect the kinetic proper- 
ties of LDHA subunits in AB heterotetramers in essentially 
the same fashion as the normal B subunits [13] and the 
studies of the Gln-109 variant, we assumed that the Arg to 
Trp substitution does not result in global conformational 
changes of the LDHB*GUA1 subunits. Therefore, all 
three LDHB* GUA1 models were held fixed to original 
crystallographic coordinates, while possible conformations 
of the introduced Trp residue were investigated. The low- 
est energy structure for each of these three LDHB * GUA1 
models resulted in the Trp side-chain positioned such that 
a hydrogen bond was formed between the polar indole 
hydrogen of Trp and the carbonyl oxygen of the substrate 
(Table 2; Fig. IB). In none of the energy-minimized 
models were unfavorable contacts observed between Trp- 
109 and neighboring residues of the active site. These 
results indicate that loop closure would not be sterically 
hindered by the presence of Trp at residue 109. In addi- 
tion, hydrogen bonding of Trp with the abortive substrates 
(oxamate or S-lac-NAD) in the model structures i similar 
to, though not as strong as, the Arg-109-substrate interac- 
tion in the wild-type structure (Fig. I A). This suggests that 
Trp-109 would not interfere with substrate binding. How- 
ever, since Arg-109 has been implicated to play an impor- 
tant role in the mechanism of loop closure [5], we cannot 
rule out the possibility that catalytic activity may be 
severely reduced in the variant due to alterations in the 
mechanism of loop closure. Given that the data suggest 
that the Trp for Arg substitution does not disrupt the 
conformation of the active site, it would seem that the loss 
of catalytic activity is associated with the direct involve- 
ment of Arg-109 in catalysis rather than substantive alter- 
ations in subunit conformation, a conclusion supported by 
analysis of the Gln-109 variant [9,26]. 
While the computer generated models of LDHB * GUA1 
suggest no evidence of steric hindrance when Trp is 
substituted for Arg- 109, the Trp- 109 is sufficiently close to 
His-195, such that a slight repositioning of either side-chain 
would allow favorable Van der Waals contacts between 
aromatic rings in these models. A study of aromatic side- 
chains in very close proximity to His residues in other 
enzymes indicates that aromatic-His interactions can stabi- 
lize the protonated form of His (by 0.8 to 1 kcal tool -~) 
relative to the unprotonated form, raising its pK a value 
[28]. Thus, His-195-Trp-109 interactions in the variant 
subunit may also be responsible for a reduction of catalytic 
function by significantly reducing the rate of proton trans- 
fer from His-195 to the substrate. 
Thus, all of the data suggest hat when the Arg-109 
residue is replaced by the Trp residue, the loss of catalytic 
function results from the direct role of the Arg residue in 
catalysis. The computer modeling results that are based on 
previous X-ray crystallography data, in conjunction with 
the data from analysis of the Arg 109 to Gln mutant [26], 
suggest that the observed catalytic inactivity of 
LDHB* GUAI subunits can best be explained by the 
inability of the neutral Trp-109 to function in substrate 
polarization. The potential His-195-Trp-109 aromatic inter- 
action could exacerbate the loss of catalytic function due 
to the inability of Trp-109 to polarize substrate by reduc- 
ing the rate of proton transfer from His-195 to the sub- 
strate. 
The C-G to T .A  transition in exon 4 of the 
LDHB* GUA1 allele resulting in the Arg-109 to Trp sub- 
stitution is consistent with, and sufficient o explain, the 
Table 2 
Torsional angles and relative energies of selected LDHB Trp-109 conformers 
Conformer X 1 Xo Eo X~ X} E r 
CON 1.1LDM * - 50 90 47 - 47 86 0 
CON2.1LDM 0 - 100 21 - 6 - 94 6 
CON3.1LDM 80 150 153 79 131 41 
CON4.5LDH ~ - 80 80 46 - 80 83 0 
CON5.5LDH ~ - 90 20 51 - 95 19 2 
CON6.5LDH 60 - 50 110 73 - 28 11 
CON7.5LDH - 50 - 60 72 - 53 - 77 20 
CON8.9LDB ~ - 30 80 36 - 43 82 0 
CON9.9LDB 50 - 40 265 24 - 94 10 
CON10.9LDB 10 - 100 110 - 10 93 86 
X~I and Xo are the Trp-109 torsional angles of conformers with energy Eo which were selected for energy minimization as described in Section 2. g} ,  Xf 
and Ef  are the torsional angles and energies of the conformers after energy minimization. File entensions denote the parent PDB file of each particular 
conformer. Energy values are in kca l /mol  and represent relative values with respect o the lowest energy conformer for a particular PDB parent structure. 
Torsional angles are given in degrees. Asterisks denote conformers in which Trp-109 is hydrogen bonded to substrate analogs as shown in Fig. lB. 
14 G.C. Shonnard et al. / Biochimica et Biophysica Acta 1315 (1996) 9-14 
electrophoretic mobility shift and loss of catalytic function. 
The modeling of the active site conformation suggests: (1) 
the Arg-109 to Trp substitution does not significantly 
disrupt he conformation of the active site, and (2) that the 
loss of catalytic function is due to the inability of the 
neutral Trp-109 residue to polarize the carbonyl bond of 
the substrate which may be further impeded by a reduction 
in the rate of proton transfer from His-195. The data are 
consistent with the previous observations that the residual 
LDH activity in erythrocytes of homozygous variant (defi- 
cient) individuals, approx. 20% of normal and due entirely 
to the presence of the LDHA subunits, has kinetic proper- 
ties similar to the enzyme in erythrocytes from normal 
individuals. In contrast to other LDHB-deficient individu- 
als [23-25], these homozygous-deficient individuals do not 
exhibit clinical symptoms of LDH deficiency. This is 
probably a reflection of the fact that the residual activity in 
the LDHB * GUA1 individuals has normal, tissue-specific 
kinetic properties. This catalytically inactive variant, with 
apparently normal conformation, provides an interesting 
model for the study of subunit interaction and communica- 
tion. 
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